Effect of Moderate to Severe Hepatic Steatosis on Vaccine Immunogenicity against Wild-Type and Mutant Virus and COVID-19 Infection among BNT162b2 Recipients.

Ka Shing CheungLok Ka LamXianhua MaoJing Tong TanPoh Hwa OoiRicky Rui-Qi ZhangKwok Hung ChanIvan F N HungWai Kay SetoMan Fung Yuen

Published in: Vaccines (2023)

NAFLD patients receiving two doses of BNT162b2 had good immunogenicity to wild-type SARS-CoV-2 and the delta variant but not the omicron variant, and they were not at higher risk of infection compared with controls.

Keyphrases

wild type
sars cov
respiratory syndrome coronavirus
high intensity
early onset
kidney transplantation
drug induced